ABSTRACT

Fact Sheet for Healthcare Providers: DxTerity Diagnostics, Inc., DxTerity SARS-CoV-2 RT-PCR CE Test   [open pdf - 143KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the DxTerity SARS-CoV-2 RT-PCR CE [severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction capillary electrophoresis] Test. The DxTerity SARS-CoV-2 RT-PCR CE Test is authorized for use with saliva specimens collected from individuals consistent with the EUA [emergency use authorization]."

Publisher:
Date:
2020-08-28
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations